miR-141-3p increases cetuximab sensitivity and cetuximab-induced apoptosis, decreases EMT marker expression, suppresses proliferation, migration, and invasion in CRC cells by targeting EGFR pathway. The gene discussed is EGFR; the disease is colorectal carcinoma.